Trial Profile
A Multiple Dose, PhaseII Clinical Trial to Assess the Pharmacokinetics of KRP-AB1102 in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 09 Jun 2016
Price :
$35
*
At a glance
- Drugs Aclidinium bromide (Primary)
- Indications Chronic obstructive pulmonary disease
- Focus Pharmacokinetics
- Sponsors Kyorin Pharmaceutical
- 09 Jun 2016 New trial record